Investor Call

Vistra Corp. will release its Q4 and full-year 2025 financial results on February 26, 2026, with an investor call at 10 a.m. ET. The company, operating a diverse generation portfolio including renewables and storage, faces industry shifts driven by regulations and technology. Investors anticipate updates on performance across segments, renewable investments, market dynamics, and capital allocation strategies. A webcast and phone participation options are available, with a replay accessible for a year.

Itaú Unibanco will release its 4Q25 and full-year 2025 earnings on February 4, 2026. An interactive investor call, in both Portuguese and English, will follow on February 5, 2026. Executives including CEO Milton Maluhy and CFO Gabriel Amado de Moura will discuss performance, strategy, and outlook. Investors can register and access materials on the Investor Relations website. The call will offer insights into credit growth, digital transformation, and macroeconomic trends.

Crinetics Pharmaceuticals will host an investor call on January 5th, 2026, to discuss PALSONIFY’s commercialization strategy and present topline Phase 2 data for atumelnant in congenital adrenal hyperplasia. Management will provide updates on their go-to-market plan for PALSONIFY and share results from the fourth cohort of the atumelnant trial, offering insights into the company’s pipeline and future prospects.

OBOOK Holdings has rescheduled its H1 2025 earnings call to December 29th. This follows recent strategic updates, including a Visa partnership for OwlPay Cash and growth figures for OwlNest. Investors will be keen to see quantitative results validating these initiatives and OBOOK’s blockchain strategy during the call.

BIO-key International (BKYI) will release its Q3 2025 results before market open on November 14, 2025, followed by an investor call at 10:00 a.m. ET. CEO Mike DePasquale and CFO Cecilia Welch will lead the call, discussing company performance and strategic initiatives. A live webcast and replay will be available to investors. The call will include a Q&A session, and the webcast replay will be accessible for three months. Dial-in details are provided for both U.S. and international participants.